Actinobac Biomed, Inc.
Pharmaceutical company · Kendall Park, New Jersey, United States
Actinobac Biomed, Inc. is a pharmaceutical company headquartered in Kendall Park, New Jersey, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.1 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2018.
Actinobac Biomed at a glance
What does Actinobac Biomed do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.1 million in total (2012 to 2014). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1 million sold (2018).
Frequently asked questions about Actinobac Biomed
Where is Actinobac Biomed headquartered?
Actinobac Biomed, Inc. is headquartered in Kendall Park, New Jersey, United States.
What does Actinobac Biomed do?
Actinobac Biomed, Inc. is a pharmaceutical company.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences